02nd week of 2017 patent applcation highlights part 22 |
Patent application number | Title | Published |
20170008866 | CATALYST SYSTEM FOR OXIDIZING O-XYLOL AND/OR NAPHTHALENE INTO PHTHALIC ANHYDRIDE | 2017-01-12 |
20170008867 | CATALYST SYSTEM FOR OXIDATION OF O-XYLENE AND/OR NAPHTHALENE TO PHTHALIC ANHYDRIDE | 2017-01-12 |
20170008868 | PROCESS FOR THE PRODUCTION OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL | 2017-01-12 |
20170008869 | PROCESS FOR THE PRODUCTION OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL | 2017-01-12 |
20170008870 | Methods for Obtaining Purified Cannabis Extracts and THCA Crystals | 2017-01-12 |
20170008871 | 2-HYDROXYETHYL 2-OXO-1,3-DIOXOLANE-4-CARBOXYLATES, THEIR PREPARATION AND USE | 2017-01-12 |
20170008872 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | 2017-01-12 |
20170008873 | COT MODULATORS AND METHODS OF USE THEREOF | 2017-01-12 |
20170008874 | Method for Producing Sulfonyl Chloride Compound | 2017-01-12 |
20170008875 | OXINDOLE DERIVATIVES CARRYING A PIPERIDYL-SUBSTITUTED AZETIDINYL SUBSTITUENT AND USE THEREOF FOR TREATING VASOPRESSINE-RELATED DISEASES | 2017-01-12 |
20170008876 | Metal Chelate Compounds for Binding to the Platelet Specific Glycoprotein IIb/IIIa | 2017-01-12 |
20170008877 | BICYCLIC LACTAMS AND METHODS OF USE THEREOF | 2017-01-12 |
20170008878 | HETEROCYCLIC AMIDES AS KINASE INHIBITORS | 2017-01-12 |
20170008879 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | 2017-01-12 |
20170008880 | NEPRILYSIN INHIBITORS | 2017-01-12 |
20170008881 | DIHYDROOXAZINE OR OXAZEPINE DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY | 2017-01-12 |
20170008882 | PYRIDINES AND PYRIMIDINES AND USE THEREOF | 2017-01-12 |
20170008883 | SUBSTITUTED THIAZOLE OR OXAZOLE P2X7 RECEPTOR ANTAGONISTS | 2017-01-12 |
20170008884 | NOVEL CYSTEINE PROTEASE INHIBITORS AND USES THEREOF | 2017-01-12 |
20170008885 | PYRROLO[3,2-C]PYRIDINE DERIVATIVES AS TLR INHIBITORS | 2017-01-12 |
20170008886 | A PROCESS FOR THE PREPARATION OF APIXABAN AND ITS INTERMEDIATES | 2017-01-12 |
20170008887 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2017-01-12 |
20170008888 | HETEROCYCLIC COMPOUNDS | 2017-01-12 |
20170008889 | 2,4-DISUBSTITUTED PHENYLENE-1,5-DIAMINE DERIVATIVES AND APPLICATIONS THEREOF, AND PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS PREPARED THEREFROM | 2017-01-12 |
20170008890 | SUBSTITUTED 4-AZAINDOLES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | 2017-01-12 |
20170008891 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2017-01-12 |
20170008892 | PROCESS FOR PREPARATION OF SODIUM (2S, 5R)-6-(BENZYLOXY)-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXYLATE | 2017-01-12 |
20170008893 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 8-[-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE COMPOUNDS | 2017-01-12 |
20170008894 | COMPOUNDS AS MODULATORS OF ROR GAMMA | 2017-01-12 |
20170008895 | USES OF DIAZEPANE DERIVATIVES | 2017-01-12 |
20170008896 | HETEROARYL SYK INHIBITORS | 2017-01-12 |
20170008897 | PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | 2017-01-12 |
20170008898 | Cyclic Amines | 2017-01-12 |
20170008899 | BTK INHIBITORS | 2017-01-12 |
20170008900 | BICYCLIC COMPOUNDS AS AUTOTAXIN (ATX) AND LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION INHIBITORS | 2017-01-12 |
20170008901 | SPIRO-OXAZOLONES | 2017-01-12 |
20170008902 | IMPROVED GLYCOL ACYLATION PROCESS WITH WATER-TOLERANT METAL TRIFLATES | 2017-01-12 |
20170008903 | NOVEL PIPERIDINO-DIHYDROTHIENOPYRIMIDINE SULFOXIDES AND THEIR USE FOR TREATING COPD AND ASTHMA | 2017-01-12 |
20170008904 | MDM2-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE | 2017-01-12 |
20170008905 | COT MODULATORS AND METHODS OF USE THEREOF | 2017-01-12 |
20170008906 | INHIBITORS OF HEPATITIS C VIRUS REPLICATION | 2017-01-12 |
20170008907 | Compounds and Derivatives of 2H-Pyrido (3,2-b)(1, 4) Oxazin 3)4H)-Ones as raf Kinase and LRRK2 Inhibitors | 2017-01-12 |
20170008908 | PYRIDIN-3-YL ACETIC ACID MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2017-01-12 |
20170008909 | PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2017-01-12 |
20170008910 | THIAZOLOPYRROLIDINE INHIBITORS OF ROR-GAMMA | 2017-01-12 |
20170008911 | 2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,- 3-Thiazol-4-yl Amides | 2017-01-12 |
20170008912 | BENZOTHIAZOLE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2017-01-12 |
20170008913 | CONDENSED [1,4] DIAZEPINE COMPOUNDS AS AUTOTAXIN (ATX) AND LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION INHIBITORS | 2017-01-12 |
20170008914 | LANTHANUM COMPOUND, METHOD OF SYNTHESIZING LANTHANUM COMPOUND, LANTHANUM PRECURSOR COMPOSITION, METHOD OF FORMING THIN FILM, AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE | 2017-01-12 |
20170008915 | ACID, SOLVENT, AND THERMAL RESISTANT METAL-ORGANIC FRAMEWORKS | 2017-01-12 |
20170008916 | CARBONATE PRODRUGS AND METHODS OF USING THE SAME | 2017-01-12 |
20170008917 | METHOD FOR PREPARING RACEMIC OR OPTICALLY ACTIVE alpha-GLYCEROPHOSPHORYLCHOLINE | 2017-01-12 |
20170008918 | NOVEL CYP-EICOSANOID DERIVATIVES | 2017-01-12 |
20170008919 | CRYSTALLINE FORM OF OXAZOLIDINONE ANTIBIOTICS AND PREPARATION METHOD, COMPOSITION AND USE THEREOF | 2017-01-12 |
20170008920 | MAMMALIAN METABOLITES OF STEROIDS | 2017-01-12 |
20170008921 | C-3 NOVEL TRITERPENONE WITH C-28 REVERSE AMIDE DERIVATIVES AS HIV INHIBITORS | 2017-01-12 |
20170008922 | BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND | 2017-01-12 |
20170008923 | SOLUTION PHASE SYNTHESIS AND CRYSTALLIZATION OF BETA-TURN PEPTIDOMIMETIC CYCLIC SALTS | 2017-01-12 |
20170008924 | PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME | 2017-01-12 |
20170008925 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME | 2017-01-12 |
20170008926 | RARE EARTH MATERIAL-BINDING PEPTIDE AND USE THEREOF | 2017-01-12 |
20170008927 | ARTIFICIAL CATALYST SYSTEM SUBSTITUTABLE FOR IN VIVO ACYLATION FUNCTION | 2017-01-12 |
20170008928 | NOVEL PEPTIDES AND PEPTIDE DERIVATIVES AND USES THEREOF | 2017-01-12 |
20170008929 | SOCS MIMETICS FOR THE TREATMENT OF DISEASES | 2017-01-12 |
20170008930 | STABILIZED ALPHA HELICAL PEPTIDES AND USES THEREOF | 2017-01-12 |
20170008931 | Melanocortin-1 Receptor-Specific Cyclic Hexapeptides | 2017-01-12 |
20170008932 | USPA2 PROTEIN CONSTRUCTS AND USES THEREOF | 2017-01-12 |
20170008933 | MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES | 2017-01-12 |
20170008934 | BACTERIALLY FORMED MICROCIN S, A NEW ANTIMICROBIAL PEPTIDE, EFFECTIVE AGAINST PATHOGENIC MICROORGANISMS, E.G. ENTEROHEMORRHAGIC ESCHERICHIA COLI (EHEC) | 2017-01-12 |
20170008935 | MUTATED SALMONELLA ENTERIACA | 2017-01-12 |
20170008936 | Polypeptide Libraries With A Predetermined Scaffold | 2017-01-12 |
20170008937 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CLOSTRIDIUM INFECTION | 2017-01-12 |
20170008938 | POLYMER PARTICLES AND USES THEREOF | 2017-01-12 |
20170008940 | Mucin Derived Polypeptides | 2017-01-12 |
20170008941 | METHOD FOR PURIFYING PEGylated ERYTHROPOIETIN | 2017-01-12 |
20170008942 | IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE | 2017-01-12 |
20170008943 | STABLE GLUCAGON ANALOGUES AND USE FOR TREATMENT OF HYPOGLYCAEMIA | 2017-01-12 |
20170008944 | Exendin-4 Derivatives as Selective Peptidic Dual GLP-1/Glucagon Receptor Agonists | 2017-01-12 |
20170008945 | Novel Insulin Derivatives and the Medical Uses Hereof | 2017-01-12 |
20170008946 | MIMETIC PEPTIDES AND THEIR USE IN MEDICINE | 2017-01-12 |
20170008947 | Expression of Chimeric Polypeptide with Variable Lymphocyte Receptors on Immune Cells and Uses for Treating Cancer | 2017-01-12 |
20170008948 | METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE | 2017-01-12 |
20170008949 | Use of the binding domain of a subunit of a multi-subunit structure for targeted delivery of pharmaceutically active entities to the multi-subunit structure | 2017-01-12 |
20170008950 | HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | 2017-01-12 |
20170008951 | FUSION PROTEINS COMPRISING IGG2 HINGE DOMAINS | 2017-01-12 |
20170008952 | MEANS AND METHODS FOR PRODUCING STABLE ANTIBODIES | 2017-01-12 |
20170008953 | METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS | 2017-01-12 |
20170008954 | Monoclonal Antibodies that Modulate Immunity to MTB and Enhance Immune Clearance | 2017-01-12 |
20170008955 | HUMANIZED BETA-AMYLOID BINDING MOLECULES AND USES THEREOF | 2017-01-12 |
20170008956 | COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND MUSCLE STRENGTH BY SPECIFICALLY ANTAGONIZING GDF8 AND OR ACTIVIN A | 2017-01-12 |
20170008957 | ANTIBODY THERAPEUTICS WITH LOCAL ACTIVITY IN THE DIGESTIVE TRACT | 2017-01-12 |
20170008958 | ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS | 2017-01-12 |
20170008959 | AGER-PEPTIDES AND USE THEREOF | 2017-01-12 |
20170008960 | TCR Complex Immunotherapeutics | 2017-01-12 |
20170008961 | Improved Methods for the Treatment of Vascularizing Cancers | 2017-01-12 |
20170008962 | THERAPEUTIC PEPTIDES | 2017-01-12 |
20170008963 | TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR | 2017-01-12 |
20170008964 | ANTIBODY DRUG CONJUGATES | 2017-01-12 |
20170008965 | ANTI-PROLACTIN RECEPTOR ANTIBODY FORMULATIONS | 2017-01-12 |
20170008966 | Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD28-Positive Hematological Malignancies | 2017-01-12 |